Jolt on the Growth Health Tech Tour 2023

We don't do biotech (yet) but of course, as an investor obsessed with deeptech, we have a keen eye for healthtech and medtech.

Sensors and data. Personalized medicine. Surgical and care robots. Applied AI. Diagnostic devices. And more.

Jolt Capital just joined the Growth Health 2023 edition of Tech Tour (Lausanne, June 19th-21st)

Eric Arnould was on stage, sharing our views on the current market environment and trends for fundraising, and moderating the pitching session “Digital Health – Cross-indication Big Data and clinical studies”.

A good opportunity to catch up with fellow investors and promising entrepreneurs in the fast-growing digital health and digital therapeutics sector.

We are eager to screen more European scale-ups that could join our portfolio, alongside BC Platforms, AlphaMOS and Boydsense.

Investors on the panel : Susana Amorim (Gilde), Jean Chaoui (Stryker), Peter Ohnemus (Dacadoo), Sébastien Woynar (LBO France).

Companies : Antidote Technologies, Creal, Lynxcare, Metadvice, Promptly Health, Tribun Health, Withings.

Full program here.